Key Takeaways OPK posted a Q2 loss of 19 cents per share, missing estimates and widening from a loss of a penny a year ago.OPKO Health's Q2 revenue fell 13.9% year over year to $156.8 million due to lower diagnostics service sales.OPKO Health's gross margin rose 315 bps to 31.5% as product sales held steady and SG&A costs declined.OPKO Health, Inc. (OPK) delivered a loss per share of 19 cents in the second quarter of 2025, wider than the year-ago period’s loss of a penny per share and the Zacks Consensus Es ...